Cohort study on tuberculosis in children in Italy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather epidemiological data on tuberculosis (TB) in the pediatric population across multiple centers in Italy. It focuses on children aged 0-18 years who are affected by active or latent TB, as well as those exposed to TB but found to be non-infected. The study addresses the significant underreporting of TB cases in children due to diagnostic challenges and the lack of integration between pediatric healthcare providers and national surveillance systems. By collecting and analyzing data, the study seeks to improve understanding and management of TB in this vulnerable population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pediatric patients (0-18 years old) at the time of the initial observation
* Patients affected by active and latent TB, as defined by the criteria of the World Health Organization
* Patients exposed to TB who are found to be non-infected at the end of the window period
* Informed consent signed by parents/legal guardian or by the patient who has reached the legal age of consent, assent of the minor

Exclusion Criteria:

* None

Where it's running

• Meyer Children's Hospital IRCCS
  Florence, Firenze, Italy Recruiting
• Ospedale Pediatrico Giovanni XXIII
  Bari, Italy Recruiting
• Ospedale di Belluno
  Belluno, Italy Recruiting
• Università di Bologna
  Bologna, Italy Recruiting
• IRCCS Istituto Giannina Gaslini
  Genova, Italy Recruiting
• Fondazione IRCCS Ca' Granda, Ospedale Maggiore, Policlinico
  Milan, Italy Recruiting

Study contacts

• Study coordinator: Luisa Galli, MD
• Email: luisa.galli@meyer.it
• Phone: +390555662439

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Window-period preventive treatment to prevent TB infection in children and adolescents.

  This trial will try weekly isoniazid plus rifapentine for 12 weeks to see if it prevents TB infection in household contacts aged 5 to 17 years who are IGRA-negative after recent exposure.

  Recruiting at 5 sites Pontificia Universidad Catolica de Chile · Calama, Antofagasta and 12 other locations · NCT07086820

• Understanding how tuberculosis affects the placenta during pregnancy

  This study is trying to see how tuberculosis affects the placenta and pregnancy outcomes in women giving birth in Ethiopia.

  Recruiting Lund University · Addis Ababa · NCT06352970

• Understanding TB Infection Risks in Health Workers

  This study is trying to understand how health workers in Cape Town respond to tuberculosis infections over a year to find better ways to protect them from getting sick.

  Recruiting Beth Israel Deaconess Medical Center · Cape Town · NCT06221488

• Examining Latent Tuberculosis Infection in Health-care Workers and Students

  This study looks at how many health care workers and students have Latent Tuberculosis Infection without symptoms and what factors might put them at risk.

  Recruiting Catholic University of the Sacred Heart · Roma · NCT05756582

• Evaluating dolutegravir in children with HIV and TB receiving different doses of rifampicin

  This study is testing how safe and effective a medication called dolutegravir is for young children with both HIV and TB who are taking different doses of another medicine called rifampicin.

  Recruiting Phase 1 Brigham and Women's Hospital · Ibadan, Oyo State · NCT05069688

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.